Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

The University Of Birmingham patents

Recent patent applications related to The University Of Birmingham. The University Of Birmingham is listed as an Agent/Assignee. Note: The University Of Birmingham may have other listings under different names/spellings. We're not affiliated with The University Of Birmingham, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | The University Of Birmingham-related inventors

Ventilator system

A ventilator system (10) comprising: a ventilator (110) operable to provide forced mechanical ventilation; a breathing pattern controller (111) configured to operate the ventilator according to a breathing pattern; and a breathing pattern communication unit (112) operable to in use transmit a trigger signal, according to the breathing pattern. The ventilator system (10) may further comprises an associated medical device (113), with the breathing pattern communication unit (112) configured to transmit a trigger signal to the associated medical device (113).. ... The University Of Birmingham

Inhibitory immunoglobulins

The present invention relates to methods for identifying the presence or elevated levels of igg2 specific for o-antigen of gram-negative bacteria in a subject. The method comprises providing a binding agent specific for said igg2, contacting the binding agent with the sample, allowing the binding agent and igg2 to form a complex and thereafter directly or indirectly detecting the complex. ... The University Of Birmingham

Wound treatment

The application discloses hydrogel wound treatment formulation containing collagen and decorin, and optionally fibrin. This is especially useful for the treatment of the eye. ... The University Of Birmingham

Magnet production

A process is provided for the production of rare earth magnets comprising the steps of exposing a rare earth alloy to hydrogen gas at an elevated temperature so as to effect hydrogenation and disproportionation of the alloy, mechanically processing the disproportionated alloy, and degassing the processed alloy so as to effect hydrogen desorption and recombination of the alloy. The process of the invention finds use in the production and shaping of rare earth magnets, and may be particularly applicable to the production of thin magnetic sheets.. ... The University Of Birmingham

Apparatus and method for improved molecular detection

Provided is a method that utilises linear dichroism (ld) to identify the presence of a target molecule (l) in a sample. The method comprises providing an alignable scaffold (20), preferably biomolecular fibre m13, comprising a first binding region and having a high aspect ratio of greater than 5:1, providing a substrate (e.g. ... The University Of Birmingham

Elimination of commutation failure by hybrid hvdc system

A line commutated converter, lcc, for a high-voltage, direct current, hvdc, power converter comprises at least one bridge circuit for connection to at least one terminal of a dc system. Each bridge circuit comprises a plurality of arms, and each arm is associated with a respective phase of an ac system. ... The University Of Birmingham

Biomarkers of traumatic brain injury

Provided is a method of diagnosing and/or monitoring mild traumatic brain injury (mtbi) or concussion in a subject. The method comprises determining a level of at least one mirna in a saliva sample from the subject. ... The University Of Birmingham

Use of vap-1 inhibitors for treating fibrotic conditions

. . The present invention relates to inhibitors of vap-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble vap-1 or ssao activity in a bodily fluid, and to a kit for use in said diagnostic method.. ... The University Of Birmingham

Bladder cancer prognosis

The present invention concerns the use of protein biomarkers for use in facilitating in the prognosis and/or treatment regime of bladder cancer. In particular, the invention relates to the use of shed protein fragments, such as fragments of epithelial cell adhesion molecule (epcam) and/or epidermal growth factor receptor (egfr) detected in a sample of urine, as biomarkers for use in facilitating the prognosis and/or treatment regime of urothelial bladder cancer.. ... The University Of Birmingham

Target peptides for immunotherapy and diagnostics

A set of target peptides are presented by hla a*0101, a*0201, a*0301, b*4402, b*2705, b*1402, and b*0702 on the surface of disease cells. They are envisioned to among other things (a) stimulate an immune response to the proliferative disease, e.g., cancer, (b) to function as immunotherapeutics in adoptive t cell therapy or as a vaccine, (c) facilitate antibody recognition of tumor boundaries in surgical pathology samples, (d) act as biomarkers for early detection and/or diagnosis of the disease, and (e) act as targets in the generation antibody-like molecules which recognize the target-peptide/mhc complex.. ... The University Of Birmingham

Microfluidic devices and fabrication

Methods for mass production of new microfluidic devices are described. The microfluidic devices may include an array of micro-needles with open channels in fluid communication with multiple reservoirs located within a substrate that supports the micro-needles. ... The University Of Birmingham

Elevated intracranial pressure treatment

Provided is an incretin, or analogue thereof, an incretin receptor agonist, an incretin enhancer, or any combination thereof, for use in a method of reducing elevated intracranial pressure (icp) in a subject. Methods of reducing elevated icp in a subject may comprise administering an incretin, or analogue thereof, an incretin receptor agonist, an incretin enhancer, or any combination thereof to the subject. ... The University Of Birmingham

Markers for atrial fibrillation (af)

The present invention relates to a method for identifying whether or not it may be appropriate to administer to a subject a therapy for alleviating any potential consequences which may arise due to the subject having an atrial fibrillation (af), the method comprising detecting, in a sample of fluid from the subject, a level of ccl21 and/or ddit4 expression and determining whether or not it may be appropriate to administer to the subject a therapy for alleviating any consequences which may arise due to the subject having af, based upon the ccl21 and/or ddit4 expression level detected. Also provided are an anticoagulant or other af therapy and a method of administering an anticoagulant drug or another af therapy.. ... The University Of Birmingham

Improved molecular detection system

A molecular sensor that utilises dichroism can be used to identify the presence of a target nucleic acid molecule in a sample, for example during or after amplification reactions such as pcr/thermocyling reactions and isothermal reactions. A sensor element for use in the molecular sensor may comprise an alignable scaffold/receptor complex, the receptor of said complex comprising a nucleic acid sequence which is complementary to at least a portion of a target nucleic acid molecule.. ... The University Of Birmingham

07/06/17 / #20170191927

Improved molecular detection system

A molecular sensor that utilises dichroism can be used to identify the presence of specific molecules in a substance. The molecular sensor includes a sensor element comprising (i) a scaffold moiety and (ii) one or more receptor molecules for the target molecule attached to the scaffold moiety to form a scaffold/receptor complex, wherein the scaffold/receptor complex is modified to incorporate a chromophore and the modified scaffold/receptor complex has a high aspect ratio.. ... The University Of Birmingham

06/01/17 / #20170151309

Peptide and uses therefor

Provided is a method for treatment and/or prophylaxis of a condition associated with t cell mediated chronic inflammatory disease by administration, to a patient, of a peptide comprising n′-svteqgaelsneer-c′ (seq id no: 1) or an analogue thereof that inhibits t cell migration. Also provided is the peptide or its analogue for use in the methods of treatment and/or prophylaxis of said condition. ... The University Of Birmingham

05/04/17 / #20170121768

Atrial fibrillation therapy

Provided is a method of facilitating the determination of treatment of a subject displaying atrial fibrillation, the method comprising determining a level of pitx2c expression in a sample from the subject and selecting a treatment based upon the level of pitx2c expression. Treatment with a sodium channel blocker may be selected if the level of pitx2c expression is determined to be reduced or below a predetermined threshold. ... The University Of Birmingham

04/13/17 / #20170105276

Controlled atom source

A method of generating at least one trapped atom of a specific species, the method comprising the steps of : positioning a sample material (18) comprising a specific species in a vacuum (14); generate an atomic vapour (20) of the specific species by irradiating the sample material with a first laser (12); trapping one or more atoms from the generated atomic vapour.. . ... The University Of Birmingham

03/09/17 / #20170065952

Pickering emulsion formulations

The invention provides an emulsion comprising: (a) a continuous phase; (b) a dispersed phase comprising an active compound (1); and (c) colloidal particles located at the interface between the continuous phase and the dispersed phase. These are particularly useful with one or more agrochemicals or food additives as an active compound.. ... The University Of Birmingham

01/19/17 / #20170016893

Molecular sensor preparations and uses thereof

The present invention relates to a method of preparing a molecular sensor that is specific for a target molecule having a saccharide or peptide region. The method comprises using the target molecule as a template and incubating the template with a receptor to form a template-receptor complex. ... The University Of Birmingham

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with The University Of Birmingham in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for The University Of Birmingham with additional patents listed. Browse our Agent directory for other possible listings. Page by